Answers are grounded in this paper and cite their sources.
This is a review of the 94th Annual Meeting of the British Association of Dermatologists, held in Glasgow from 1 to 3 July 2014. The conference covered some of the latest developments in the treatment of atopic dermatitis, psoriasis and cancer, a follow-up on the methylisothiazolinone contact allergy epidemic, advances in genetically inherited disorders and somatic mutations underlying birth marks. In addition, there was an international perspective on vitiligo, leprosy and HIV, and a session discussing the regulatory process behind pharmaceutical development.
No takes yet. Share an insight, caveat, or question.
Porter et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: